| KMB |
Report |
Adjusted EPS |
IN-LINE |
pred ~$1.630 vs. cons $1.619 |
LOW |
| KMB |
Report |
Net sales |
IN-LINE |
pred ~$4.210B vs. cons $4.224B |
LOW |
| KMB |
Report |
Organic sales growth |
MISS |
pred ~1.10% vs. cons 1.18% |
LOW |
| KMB |
Guide |
FY26 organic-sales framework |
BETTER |
guide at/above ~2.5% category growth vs. cons 2.45% |
LOW |
| KMB |
Guide |
FY26 adjusted operating-profit growth |
UNCHANGED |
guide mid-to-high-single-digit CC growth vs. cons UNVERIFIED |
LOW |
| KMB |
Guide |
FY26 adjusted EPS attributable to KMB |
UNCHANGED |
guide flat CC growth vs. cons UNVERIFIED |
LOW |
| KMB |
Guide |
FY26 margin expansion |
UNCHANGED |
guide +70-80 bps vs. cons UNVERIFIED |
LOW |
| KMB |
Return |
Day-1 residual (stock − beta × S&P 500) |
-2.0% |
— |
LOW |
| KMB |
Return |
5-day cumulative residual |
-3.5% (FOLLOW-THROUGH) |
FOLLOW-THROUGH — G archetype is unobserved; projected forward-estimate pressure |
LOW |